FDA authorizes Novavax's Covid vaccine

Brasil Notícia Notícia

FDA authorizes Novavax's Covid vaccine
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

Novavax’s vaccine uses an older technology found in other widely used shots, offering people an alternative to the mRNA-based Pfizer and Moderna vaccines.

Novavax’s protein-based Covid vaccine for adults, providing Americans with an alternative to the mRNA-based shots from Pfizer-BioNTech and Moderna.Full coverage of the coronavirus outbreak

The FDA’s signoff isn’t the last step: The decision will now to go the Centers for Disease Control and Prevention and its advisory committee to issue their own recommendation on how the shots should be used. The CDC’s Advisory Committee on Immunization Practices is scheduled toThe U.S. has secured 3.2 million doses of the vaccine, ready to be shipped to states once it receives the green light, the Biden administration announced Monday.

The shot has already been cleared for use in more than 40 countries, as well as the European Union, but manufacturing problems have hampered the company's efforts to be authorized in the U.S.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

NBCNewsHealth /  🏆 707. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Novavax COVID-19 vaccine: FDA authorizes fourth shot for adultsNovavax COVID-19 vaccine: FDA authorizes fourth shot for adultsNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries.
Consulte Mais informação »

Novavax Covid-19 vaccine wins FDA authorizationNovavax Covid-19 vaccine wins FDA authorizationThe FDA granted emergency use authorization to Novavax’s Covid-19 vaccine. In a trial of more than 26,000 adults, 2 doses of the Novavax Covid vaccine were over 90% effective at preventing symptomatic disease and presented no serious side effects.
Consulte Mais informação »

FDA Authorizes Novavax’s Covid-19 VaccineFDA Authorizes Novavax’s Covid-19 VaccineThe FDA has cleared use of Novavax’s Covid-19 vaccine, which uses an older technology that some people hesitant to get inoculated might be willing to get.
Consulte Mais informação »

FDA gives emergency use authorization to Novavax's Covid-19 vaccineFDA gives emergency use authorization to Novavax's Covid-19 vaccineFDA gives emergency use authorization to Novavax's Covid-19 vaccine, which uses different technology than shots already available in US.
Consulte Mais informação »

FDA Authorizes Novavax Covid Vaccine for Adults as the First New Shots in U.S. in More Than a YearFDA Authorizes Novavax Covid Vaccine for Adults as the First New Shots in U.S. in More Than a YearFDA authorization of Novavax’s vaccine was delayed for weeks as the agency reviewed changes to the company’s manufacturing process.
Consulte Mais informação »



Render Time: 2025-02-25 19:39:14